Drug repurposing to target TGF-β in chemoresistant high-grade serous ovarian cancer

被引：0
|
作者：
Wong-Brown, Michelle W. Y.
Johnson, Zlata
Salem, Saad
Matthews, Bayley G.
Ford, Caroline E.
Marsh, Deborah J.
Bowden, Nikola A.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C041
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [32] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
  • [33] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [34] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
  • [35] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [36] Principles of dormancy evident in high-grade serous ovarian cancer
    Shepherd, Trevor G.
    Dick, Frederick A.
    CELL DIVISION, 2022, 17 (01)
  • [37] Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer
    Wada, Miku
    Kukita, Asako
    Sone, Kenbun
    Hamamoto, Ryuji
    Kaneko, Syuzo
    Komatsu, Masaaki
    Takahashi, Yu
    Inoue, Futaba
    Kojima, Machiko
    Honjoh, Harunori
    Taguchi, Ayumi
    Kashiyama, Tomoko
    Miyamoto, Yuichiro
    Tanikawa, Michihiro
    Tsuruga, Tetsushi
    Mori-Uchino, Mayuyo
    Wada-Hiraike, Osamu
    Osuga, Yutaka
    Fujii, Tomoyuki
    BIOMOLECULES, 2020, 10 (12) : 1 - 12
  • [38] INVESTIGATING EPIGENOMIC INVOLVEMENT IN ACQUIRED DRUG-RESISTANCE IN HIGH-GRADE SEROUS OVARIAN CANCER
    Silva, R.
    Metoudi, M.
    Glennon, K.
    Perry, A.
    Brennan, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A335 - A335
  • [39] Repurposing colforsin daropate to treat MYC-driven high-grade serous ovarian carcinomas
    Knarr, Matthew J.
    Moon, Jamie
    Rawat, Priyanka
    DiFeo, Analisa
    Hoon, David S. B.
    Drapkin, Ronny
    SCIENCE SIGNALING, 2024, 17 (863)
  • [40] Aberrant activation of the Hedgehog signalling pathway in high-grade serous ovarian cancer: a potential therapeutic target
    Pounds, R.
    Soo, J.
    Uddin, K.
    Dawson, C.
    Kehoe, S.
    Yap, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (08) : E37 - E37
12345